Compare Neurocrine Biosciences Inc (NBIX) vs Nasdaq100 ETF (QQQ) Price & Performance

Neurocrine Biosciences IncTrade

Nasdaq100 ETFTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Nasdaq100 ETF — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Nasdaq100 ETF trades at $708.6. The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, Nasdaq100 ETF nearer its low. Which is the better fit depends on your goals.

	NBIX	QQQ
Market Cap	$17.40B	—
Sector	Health	—
52-Week High	$180.55	$746.16
52-Week Low	$123.10	$553.88
Enterprise Value	$16.49B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NBIX

Neurocrine Biosciences appoints Samir Siddhanti as Chief Business Officer to lead growth strategy.PRNewsWire · 7 hours agoBullish View details →

QQQ

iShares Nasdaq Top 30 ETF outperforms QQQ with a 30% return by focusing on mega-cap tech giants.24/7 Wall Street · 2 days agoBullish REX AI Equity Premium Income ETF offers 36.5% yield but caps upside and may return capital.24/7 Wall Street · 3 days agoNeutral Invesco's IQQQ ETF offers more Nasdaq upside than typical covered-call funds with daily call resets.24/7 Wall Street · 4 days agoNeutral View details →

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.